Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006;43(2):123-30.
doi: 10.1159/000090131. Epub 2005 Dec 7.

Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3

Affiliations

Hyperlipemia and oxidation of LDL induce vascular smooth muscle cell growth: an effect mediated by the HLH factor Id3

Angela M Taylor et al. J Vasc Res. 2006.

Abstract

Hyperlipemia and oxidized LDL (ox-LDL) are important independent cardiovascular risk factors. Ox-LDL has been shown to stimulate vascular smooth muscle cell (VSMC) proliferation. However, the effects of hyperlipemia and the molecular mechanisms mediating hyperlipemia and ox-LDL effects on VSMC growth are poorly understood. The helix-loop-helix (HLH) transcription factor, Id3, is a redox-sensitive gene expressed in VSMC in response to mitogen stimulation and vascular injury. Accordingly, we hypothesize that Id3 is an important mediator of ox-LDL and hyperlipemia-induced VSMC growth. Aortas harvested from hyperlipemic pigs demonstrated significantly more Id3 than normolipemic controls. Primary VSMC were stimulated with ox-LDL, native LDL, sera from hyperlipemic pigs, or normolipemic pigs. VSMC exposed to hyperlipemic sera demonstrated increased Id3 expression, VSMC growth and S-phase entry and decreased p21cip1 expression and transcription. Cells stimulated with ox-LDL demonstrated similar findings of increased growth and Id3 expression and decreased p21cip1 expression. Moreover, the effects of ox-LDL on growth were abolished in cells devoid of the Id3 gene. Results provide evidence that the HLH factor Id3 mediates the mitogenic effect of hyperlipemic sera and ox-LDL in VSMC via inhibition of p21cip1 expression, subsequently increasing DNA synthesis and proliferation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
ox-LDL increases linearly with total cholesterol. Levels of LDL oxidation were determined using a commercially available antibody assay. As total cholesterol increases in the porcine model, ox-LDL increases.
Fig. 2
Fig. 2
Hyperlipemia induces Id3 expression in the vessel wall. After 20 weeks of high-fat feeding, vessels were harvested and equal amounts of protein were analyzed for Id3. A representative Western blot is shown (a). Quantitative densitometry is shown from 4 animals from each group (b). Results are normalized to quantitative densitometry of the tubulin blot for each sample. Normolipemic animals had serum cholesterol levels of 65–105 mg/dl. Hyper-lipemic animals had cholesterol levels of 287–450 mg/dl. Hyperlipemic aortas demonstrated significantly more Id3 relative to normolipemic aortas (* p < 0.001).
Fig. 3
Fig. 3
Hyperlipemia increases Id3 expression, VSMC growth, and S-phase entry. Porcine VSMC were plated in equal densities, quiesced for 48 h and stimulated with media containing either hyperlipemic or normolipemic sera. Normolipemic animals had serum cholesterol levels of 65–105 mg/ dl. Hyperlipemic animals had cholesterol levels of 287–450 mg/dl. a Forty-eight hours after stimulation, equal amounts of protein were analyzed for Id3 expression by Western blotting. The blot was stripped and reprobed with an anti-tubulin antibody to control for protein loading. b VSMC stimulated with hyperlipemic sera grew faster at all time points relative to normolipemic sera (* p = 0.008 at 24 h, p = 0.01 at 48 h). c Eighteen hours after stimulation, cells were stained with PI and analyzed for cell cycle components. VSMC stimulated with hyperlipemic sera had significantly greater S-phase entry relative to normolipemic sera (* p = 0.016). Results are the average of three experiments performed in triplicate utilizing sera from 7 animals from each group.
Fig. 4
Fig. 4
Hyperlipemia increases Id3 transcription and decreases p21cip1 transcription. Cells were cotransfected with pK7GFP and either pId3Luc or p21Luc. Cells were quiesced for 48 h and stimulated with either hyperlipemic or normolipemic sera. Lucif-erase activity was measured (normalized to protein concentration and GFP fluorescence) was measured 24 and 48 h later. a Hyperlipemic sera increased Id3 promoter reporter activity relative to normolipemic sera (* p < 0.01 at 24 and 48 h). b Hyperlipemic sera decreased p21 promoter reporter activity relative to normolipemic sera (* p < 0.01 at 24 h, p = 0.02 at 48 h). Results are average of three experiments performed in triplicate utilizing sera from 7 animals from each group.
Fig. 5
Fig. 5
Id3 is essential for ox-LDL-induced growth. Control and Id3 knockout primary mouse aortic VSMC were plated at equal densities, quiesced for 48 h and stimulated with either 20 μg/ml of n-LDL or ox-LDL. a Control B6 cells stimulated with ox-LDL grew faster at all time points relative to n-LDL (* p < 0.05 at 24 h, p < 0.001 at 48 h). Id3 KO cells grew significantly slower than wild-type cells at all time points (p < 0.05 at 24 h, p < 0.001 at 48 h) and demonstrated no increase in growth in response to ox-LDL. Results are averages of three experiments performed in triplicate. b At 48 h, equal amounts of protein from control cell lysates were immunoblotted using antibodies to Id3 or p21cip1 . The blot was stripped and reprobed with an anti-tubulin antibody to control for protein loading.
Fig. 6
Fig. 6
AdId3 infection rescues decreased proliferation of Id3–/– cells. Wild-type and Id3 knockout VSMC were infected with AdId3 or AdGFP control virus and assayed for cell number 24 h after infection. Control infected Id3 knockout cells demonstrated decreased proliferation relative to control infected wild type cells. Proliferation of Id3 knockout cells is rescued with AdId3 infection.

Similar articles

Cited by

References

    1. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Internal Med. 2001;161:1413–1419. - PubMed
    1. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7–22. - PubMed
    1. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol. 1996;16:831–842. - PubMed
    1. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462–2478. - PubMed
    1. Lafont A, Libby P. The smooth muscle cell: sinner or saint in restenosis and the acute coronary syndromes? J Am Coll Cardiol. 1998;32:283–285. - PubMed

Publication types

Substances